NPHC.OB Nutra Pharma Reports Positive - Medicine & Biotech

NPHC.OB Nutra Pharma Reports Positive

Medicine & Biotech Forum

Pages:  1Original Discusssion    Popular Forums    Search

Posted by: thebigpoppa

reults for their MS drug.
Excerpt--"RPI-78M reduced the clinical symptoms by more than 80 percent," remarked neurologist Mitchell S. Felder, M.D. "There was also more than an 87 percent reduction in the number of EAE histopathologic lesions. If these results are duplicated in the human trials it could possibly revolutionize the treatment of MS. The results from an EAE model indicate that this drug may also have therapeutic potential for a great number of other neurologic conditions such as Acute Disseminated Encephalomyelitis, Transverse Myelitis, Krabbe's Leukodystrophy, Alexander's Disease, Canavan's Disease and Adrenoleukodystrophy," he concluded.
full article link at http://www.nutrapharma.com/investor/pr/10_14_04.htm

Reply To this Message

Pages:  1 Free Forums    Chat Forum

Medicine & Biotech Forum: NPHC.OB Nutra Pharma Reports Positive

Forum Forum Forum